Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,230 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,454
Recruiting: 786
Ph III recruiting: 83
Growth YoY: +22.9%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 751–800 of 2,819 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06068998	Molecular Characterization of Penile Cancers in Developing Countries	completed	—	24	Latin American Cooperative Oncology GroupOTHER	1	Oct 5, 2023	clinicaltrials
NCT00292045	Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer	completed	Phase 1	15	Ludwig Institute for Cancer ResearchOTHER	2	Oct 4, 2023	clinicaltrials